Author

Gayatri Seth

Meharry Medical College

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:development & morphogenesis· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Allston Oxenrider· 3 shared Pamela Moore MartiniD· 3 shared Ravirajsinh Navalsinh JadejaiD· 3 shared Briah BaileyiD· 2 shared Menaka Chanu ThounaojamiD· 2 shared Aleah J. BrokemondiD· 1 shared Ankit SethiD· 1 shared Chanel HarrisiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

Allston Oxenrider

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Loss of Farnesoid X Receptor Signaling Promotes Choroidal Neovascularization in Mice

Chanel Harris, Mohammed A Nisar, Ankit Seth, Allston Oxenrider, Briah Bailey, Gayatri Seth, Pamela Moore Martin, Ravirajsinh Navalsinh Jadeja, Menaka Chanu Thounaojam

This study shows that loss of FXR signaling in mice promotes choroidal neovascularization, fibrosis, and vascular leakage, suggesting FXR as a therapeutic target for nAMD.

bioRxiv · Oct 23, 2026 · PreprintBiochemistry

CYP46A1 Activation Improves Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity

Briah Bailey, Josephine Rudd Zhong Manis, Gayatri Seth, Shubhra Rajpurohit, Allston Oxenrider, Pamela Moore Martin, Ravirajsinh Navalsinh Jadeja, Menaka Chanu Thounaojam

This study shows that activating CYP46A1 reduces pathological neovascularization and improves retinal health in a mouse model of retinopathy of prematurity.

bioRxiv · Oct 14, 2025 · PreprintBiochemistry

Protective Effects of Butyrate on Retinal Neovascularization in Preclinical Retinopathy of Prematurity Models

Allston Oxenrider, Tommy Bui, John Lester, Gayatri Seth, Aleah J. Brokemond, Menaka Chanu Thounaojam, Pamela Moore Martin, Ravirajsinh Navalsinh Jadeja

This study shows that sodium butyrate protects against retinal neovascularization in preclinical ROP models by reducing vascular, neuronal, and microglial pathology.

bioRxiv · Jun 3, 2024 · PreprintPharmacology & Toxicology